Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications

Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications

Cardiovascular factors are one of the main causes of morbidity and mortality in patients with chronic kidney disease. Bone mineral metabolism disorders and inflammation are pathological conditions that involve increased cardiovascular risk in chronic kidney disease. The cardiovascular risk involveme...

Full description

Bibliographic Details
Main Authors:	Laura Salanova Villanueva, Carmen Sánchez González, José Antonio Sánchez Tomero, Abelardo Aguilera, Esther Ortega Junco
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Nefrología (English Edition)
Subjects:	Cardiovascular risk Chronic kidney disease Klotho FGF23
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251416300700

Similar Items

Enfermedad óseo mineral relacionada con la enfermedad renal crónica: Klotho y FGF23; implicaciones cardiovasculares
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01)

Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01)

Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
by: TOMŞA Anamaria Magdalena, et al.
Published: (2020-09-01)

FGF-23, Klotho and Vitamin D Levels in Scleroderma
by: Ravan AHMADI, et al.
Published: (2017-04-01)

Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis
by: Charat Thongprayoon, et al.
Published: (2020-06-01)

Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
by: Ana Paula Silva, et al.
Published: (2019-03-01)

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
by: Chen Y, et al.
Published: (2021-03-01)

FGF23 Actions on Target Tissues—With and Without Klotho
by: Beatrice Richter, et al.
Published: (2018-05-01)

Protein Klotho and FGF23 fibroblasts growth factor as markers of chronic renal disease
by: A.A. Melnik
Published: (2017-08-01)

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
by: Monika Sykała, et al.
Published: (2021-07-01)

FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients
by: Pasaoglu Ozge Tugce, et al.
Published: (2021-01-01)

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu
by: Andreja Figurek, et al.
Published: (2021-05-01)

Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
by: L Iu Milovanova, et al.
Published: (2014-04-01)

Τα επίπεδα του αυξητικού παράγοντα των ινοβλαστών 23 (FGF23) και της πρωτεΐνης Klotho σε σχέση με την ηλικία και τη νεφρική επαναρρόφηση φωσφόρου στην παιδική ηλικία
by: Γκέντζη, Δέσποινα
Published: (2015)

FGF23, Hypophosphatemia, and Emerging Treatments
by: Erik A Imel, et al.
Published: (2019-08-01)

Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patient. Far beyond mineral bone disease regulation
by: Laura Salanova Villanueva, et al.
Published: (2020-03-01)

Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
by: L Yu Milovanova, et al.
Published: (2015-06-01)

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
by: L Yu Milovanova, et al.
Published: (2018-06-01)

Role of sodium‐dependent Pi transporter/Npt2c on Pi homeostasis in klotho knockout mice different properties between juvenile and adult stages
by: Ai Hanazaki, et al.
Published: (2020-02-01)

FGF23 - a possible Phosphatonin
by: Marsell, Richard
Published: (2008)

Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease
by: Kosaku Nitta
Published: (2018-08-01)

Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
Published: (2019)

New Insights into the Mechanism of Action of Soluble Klotho
by: George D. Dalton, et al.
Published: (2017-11-01)

Soluble Alpha-Klotho Alleviates Cardiac Fibrosis without Altering Cardiomyocytes Renewal
by: Wei-Yu Chen
Published: (2020-03-01)

Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
by: Juan Rafael Muñoz-Castañeda, et al.
Published: (2020-03-01)

Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway
by: Yan‐Xia Chen, et al.
Published: (2019-07-01)

FGF23, Biomarker or Target?
by: Cristian Rodelo-Haad, et al.
Published: (2019-03-01)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
by: Reinhold G. Erben
Published: (2019-01-01)

Fibroblast growth factor-23 and Klotho in bone/mineral and parathyroid disorders
by: Krajisnik, Tijana
Published: (2009)

Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle
by: Paulo G. de Albuquerque Suassuna, et al.
Published: (2018-07-01)

Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
by: Sara Panizo, et al.
Published: (2021-01-01)

The Importance of Phosphate Control in Chronic Kidney Disease
by: Ken Tsuchiya, et al.
Published: (2021-05-01)

Klotho, Aging, and the Failing Kidney
by: Sarah Buchanan, et al.
Published: (2020-08-01)

Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes
by: Eda Dokumacioglu, et al.
Published: (2019-01-01)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
by: Maria L. Mace, et al.
Published: (2020-11-01)

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
by: Javier Donate-Correa, et al.
Published: (2019-04-01)

Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease
by: Hagen Staude, et al.
Published: (2013-03-01)

Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01)

High-protein and low-calorie diets improved the anti-aging Klotho protein in the rats’ brain: the toxic role of high-fat diet
by: Anahid Shafie, et al.
Published: (2020-10-01)

Effect of High Intensity Interval Training on the Level of Atrial Fibrillation, Fibroblast Growth Factor 23 and Klotho Protein in Male Rats with Renal Failure
by: Sina Rokhsati, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_nptpet32cn0510u7p31qgkua7s